iPSC transfection with low stress.
A drop-in replacement for today’s lipid reagents in induced pluripotent stem cells: the same workflow, with much more expression, and cells that stay pluripotent.
Higher expression in every iPSC line we tested.
GFP expression measured side by side with Lipofectamine™ Stem: in highly optimized WTC11 culture at the Marcus Center, and across six iPSC lines at Forte Biosciences, averaged over a wide range of culture conditions.
Transfected iPSCs stay pluripotent and can still differentiate.
Core pluripotency factors retained
No shift vs. untransfected controls and no spontaneous differentiation, the same result as Lipofectamine™ Stem.
Mesoderm
100%of GFP-positive cells differentiated to mesoderm.
Ectoderm
ObservedGFP-positive cells differentiated to ectoderm (abbreviated protocol).
Pluripotency by flow cytometry (OCT4, SOX2, NANOG) in GFP-positive cells; lineage markers by flow cytometry after directed differentiation.
Run 1 is at the low end of the reagent concentration range specified for both Valentrifect™ Stem and Lipofectamine™ Stem; Run 2 is at the high end. Marcus Center values are mean ± 2 percentage points; plasmid DNA expression is still developing at 24 h. Each pair is scaled on its own, so bar length compares Valentrifect™ Stem with Lipofectamine™ Stem within that cell line and run, not between them; the numbers on the bars are percent GFP-positive cells. WTC11 measurements by the Marcus Center of Excellence for Cell Biomanufacturing; the six-line comparison by Forte Biosciences.
Gentle on cells. Strong on expression.
- Cell viability above 90% in all conditions tested.
- No interferon or stress response at 6 h or 24 h across five marker genes, matching untreated cells and Lipofectamine™ Stem.
- OCT4, SOX2 and NANOG retained in GFP-positive cells, with no shift versus untransfected controls and no spontaneous differentiation.
- Transfected cells still differentiate on demand: 100% of GFP-positive cells differentiated to mesoderm, and ectoderm differentiation was also observed (abbreviated protocol).
Independent testing by Forte Biosciences, including viability. KOLF2 hiPSCs transfected with GFP mRNA; RT-qPCR for stress markers; flow cytometry for pluripotency (OCT4, SOX2, NANOG) and, after directed differentiation, lineage markers.
What you get.
See it in your own iPSCs.
We provide evaluation samples so you can compare Valentrifect™ Stem with your current reagent at your own bench.
For research use only. Not for diagnostic or therapeutic use. Lipofectamine™, MessengerMAX™ and ExpiFectamine™ are trademarks of Thermo Fisher Scientific, which is not affiliated with Valentris.
